Evolent Health, Inc. EVH
4.58 USD +0.04 (+0.88%)
At closeNov 6, 2026, 5:05 PM EST
4.56 -0.02 -0.44%
After hours · Nov 6, 5:05 PM ET
4.39 Day range 4.82
2.17 52-week range 6.19
- YTD
- +14.50%
- 1 year
- -23.67%
News
seekingalpha.com Evolent Health, Inc. (EVH) Q3 2026 Earnings Call Transcript Evolent Health, Inc. ( EVH ) Q3 2026 Earnings Call November 5, 2026 8:30 AM EST Company Participants Seth Blackley - Co-Founder, CEO & Director Mario Ramos - Chief Financial Officer Conference Call…
marketbeat.com What Evolent Health (EVH) Said on Its Q3 Earnings Call Evolent Health NYSE: EVH raised the lower end of its 2026 adjusted earnings outlook after third-quarter revenue and profitability improved from the preceding quarter, helped by growth in its…
benzinga.com Oppenheimer Maintains Outperform on Evolent Health, Raises Price Target to $7 Oppenheimer analyst Michael Wiederhorn maintains Evolent Health (NYSE:EVH) with a Outperform and raises the price target from $6 to $7.
benzinga.com Needham Maintains Buy on Evolent Health, Raises Price Target to $6 Needham analyst Matthew Shea maintains Evolent Health (NYSE:EVH) with a Buy and raises the price target from $5 to $6.
zacks.com Evolent Health (EVH) Matches Q3 Earnings Estimates Evolent Health (EVH) came out with quarterly earnings of $0.06 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.05 per share a year ago.
benzinga.com Evolent Health Q3 2026 Earnings Call Transcript Evolent Health (NYSE:EVH) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you…- benzinga.com Evolent Health Affirms FY2026 Sales Guidance of $2.600B-$2.700B vs $2.626B Est Evolent Health (NYSE:EVH) affirms FY2026 sales outlook from $2.600 billion-$2.700 billion to $2.600 billion-$2.700 billion vs $2.626 billion estimate.
benzinga.com Evolent Health Q3 Adj. EPS $0.06 Beats $0.05 Estimate, Sales $725.367M Beat $724.186M Estimate Evolent Health (NYSE:EVH) reported quarterly earnings of $0.06 per share which beat the analyst consensus estimate of $0.05 by 20 percent. This is a 20 percent increase over earnings of $0.05 per…
prnewswire.com Evolent Announces Third Quarter 2026 Results WASHINGTON, Nov. 5, 2026 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) ("Evolent" or the "Company"), a company that specializes in better health outcomes for people with complex conditions through…
benzinga.com JP Morgan Maintains Overweight on Evolent Health, Raises Price Target to $6 JP Morgan analyst John Stansel maintains Evolent Health (NYSE:EVH) with a Overweight and raises the price target from $5 to $6.
benzinga.com TD Cowen Maintains Buy on Evolent Health, Raises Price Target to $6 TD Cowen analyst Charles Rhyee maintains Evolent Health (NYSE:EVH) with a Buy and raises the price target from $5 to $6.- benzinga.com Truist Securities Maintains Hold on Evolent Health, Lowers Price Target to $6 Truist Securities analyst Jailendra Singh maintains Evolent Health (NYSE:EVH) with a Hold and lowers the price target from $7 to $6.
- benzinga.com Citigroup Upgrades Evolent Health to Buy, Lowers Price Target to $6 Citigroup analyst Daniel Grosslight upgrades Evolent Health (NYSE:EVH) from Neutral to Buy and lowers the price target from $6.75 to $6.
benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session Gainers P3 Health Partners (NASDAQ:PIII) shares increased by 24.1% to $15.92 during Monday's after-market session. The market value of their outstanding shares is at $38.5 million. As per the press…
benzinga.com Canaccord Genuity Maintains Buy on Evolent Health, Lowers Price Target to $6 Canaccord Genuity analyst Richard Close maintains Evolent Health (NYSE:EVH) with a Buy and lowers the price target from $7 to $6.
benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session Gainers Creative Medical Tech (NASDAQ:CELZ) stock increased by 86.9% to $1.25 during Thursday's pre-market session. The company's market cap stands at $4.3 million. Ensysce Biosciences (NASDAQ:ENSC)…
benzinga.com Evolent Health Raises FY2026 Sales Guidance from $2.400B-$2.600B to $2.600B-$2.700B vs $2.503B Est Evolent Health (NYSE:EVH) raises FY2026 sales outlook from $2.400 billion-$2.600 billion to $2.600 billion-$2.700 billion vs $2.503 billion estimate.
benzinga.com Evolent Health Q2 Adj. EPS $0.02 Beats $(0.02) Estimate, Sales $652.520M Beat $597.997M Estimate Evolent Health (NYSE:EVH) reported quarterly earnings of $0.02 per share which beat the analyst consensus estimate of $(0.02) by 200 percent. This is a 120 percent increase over losses of $(0.10) per…- benzinga.com TD Cowen Maintains Buy on Evolent Health, Lowers Price Target to $5 TD Cowen analyst Charles Rhyee maintains Evolent Health (NYSE:EVH) with a Buy and lowers the price target from $8 to $5.
- benzinga.com Citigroup Downgrades Evolent Health to Neutral, Raises Price Target to $6.75 Citigroup analyst Daniel Grosslight downgrades Evolent Health (NYSE:EVH) from Buy to Neutral and raises the price target from $5.5 to $6.75.
benzinga.com Canaccord Genuity Maintains Buy on Evolent Health, Raises Price Target to $7 Canaccord Genuity analyst Richard Close maintains Evolent Health (NYSE:EVH) with a Buy and raises the price target from $6 to $7.- benzinga.com Truist Securities Downgrades Evolent Health to Hold, Maintains Price Target to $7 Truist Securities analyst Jailendra Singh downgrades Evolent Health (NYSE:EVH) from Buy to Hold and maintains the price target from $7 to $7.
- benzinga.com Truist Securities Maintains Buy on Evolent Health, Raises Price Target to $7 Truist Securities analyst Jailendra Singh maintains Evolent Health (NYSE:EVH) with a Buy and raises the price target from $6 to $7.
benzinga.com Rumble, Agilon Health And Oscar Health Among Stocks Moving Higher On Thursday Stocks had mixed performance on Thursday, Dow Jones up 793 points while Nasdaq down 232 points. Rumble rose after $270M deal.- benzinga.com Citigroup Maintains Buy on Evolent Health, Raises Price Target to $5.5 Citigroup analyst Daniel Grosslight maintains Evolent Health (NYSE:EVH) with a Buy and raises the price target from $4 to $5.5.
- benzinga.com Needham Maintains Buy on Evolent Health, Raises Price Target to $5 Needham analyst Matthew Shea maintains Evolent Health (NYSE:EVH) with a Buy and raises the price target from $4 to $5.
- benzinga.com Evolent Health Affirms FY2026 Sales Guidance of $2.400B-$2.600B vs $2.487B Est. Evolent Health (NYSE:EVH) affirms FY2026 sales outlook from $2.400 billion-$2.600 billion to $2.400 billion-$2.600 billion vs $2.487 billion estimate.
- benzinga.com Evolent Health Q1 Adj. EPS $(0.02) Beats $(0.05) Estimate, Sales $496.246M Miss $534.669M Estimate. Evolent Health (NYSE:EVH) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.05) by 60 percent. This is a 133.33 percent decrease over earnings of $0.06…
benzinga.com XOMA Royalty, Oruka Therapeutics, Repay Holdings And Other Big Stocks Moving Higher On Monday U.S. stocks were lower, Dow Jones fell 0.1% on Monday. XOMA shares rose on Ligand's plans to acquire XOMA for $39.00/share. Other big gainers: MANE, ORKA, OGN, XE, PLBL, SLS, ANAB, EVH, IHRT, RPAY,…
benzinga.com Earnings Scheduled For February 24, 2026 
benzinga.com Earnings Scheduled For November 6, 2025 - benzinga.com Earnings Scheduled For August 7, 2025
- benzinga.com Earnings Scheduled For May 8, 2025
- benzinga.com Earnings Scheduled For February 20, 2025
- benzinga.com Lucid, Grifols And Amer Sports Are Among Top 8 Mid Cap Stock Gainers Last Week (Aug 18-Aug 24): Are The Others In Your Portfolio?
- benzinga.com Why Diodes Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
- benzinga.com Why MercadoLibre Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session Shares of MercadoLibre, Inc. (NASDAQ: MELI) fell sharply during Friday’s session after the company reported fourth-quarter financial results.
- benzinga.com Earnings Scheduled For February 22, 2024 Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings at $0.28 per share on revenue of $260.00 million.
- benzinga.com Why Daktronics Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session Shares of Daktronics, Inc. (NASDAQ: DAKT) moved lower during Tuesday’s session following weak quarterly results.
- benzinga.com Earnings Scheduled For November 2, 2023 Companies Reporting Before The Bell • AudioCodes (NASDAQ:AUDC) is estimated to report quarterly earnings at $0.18 per share on revenue of $61.52 million.
- benzinga.com Earnings Scheduled For August 2, 2023 Companies Reporting Before The Bell • Vanguard Extended Duration Treasury ETF (NYSE:EDV) is estimated to report quarterly earnings at $0.37 per share on revenue of $784.53 million.
- benzinga.com Earnings Scheduled For February 22, 2023 Companies Reporting Before The Bell • Rio Tinto (NYSE:RIO) is projected to report earnings for its Fiscal Year 2022.
- benzinga.com Why Harsco Shares Surged Over 22%; Here Are 80 Biggest Movers From Yesterday Gainers
- benzinga.com Earnings Scheduled For November 2, 2022 Companies Reporting Before The Bell • Nomura Holdings (NYSE:NMR) is likely to report earnings for its second quarter.
- benzinga.com Why Abiomed Shares Are Trading Higher By Over 50%? Here Are 60 Stocks Moving In Tuesday's Mid-Day Session Gainers Safe-T Group Ltd (NASDAQ: SFET) shares surged 63.7% to $0.4910 as the company said its privacy application reached over 5,000,000 downloads.
- benzinga.com Goodyear Tire, Catalent, Zebra Technologies And Some Other Big Stocks Moving Lower On Tuesday U.S. stocks traded lower, with the Dow Jones dropping more than 100 points on Tuesday. Here are some big stocks recording losses in today’s session.
- benzinga.com Earnings Scheduled For August 2, 2022 Companies Reporting Before The Bell • Ferrari (NYSE:RACE) is expected to report quarterly earnings at $1.27 per share on revenue of $1.22 billion.
- benzinga.com Earnings Scheduled For May 4, 2022 Companies Reporting Before The Bell • Seres Therapeutics (NASDAQ:MCRB) is estimated to report quarterly loss at $0.52 per share on revenue of $8.48 million.
- benzinga.com Earnings Scheduled For February 23, 2022 Companies Reporting Before The Bell • Sapiens Intl Corp (NASDAQ:SPNS) is likely to report earnings for its fourth quarter.
- benzinga.com Earnings Scheduled For November 3, 2021 Companies Reporting Before The Bell • R.R.Donnelley & Sons (NYSE:RRD) is likely to report quarterly earnings at $0.32 per share on revenue of $1.19 billion.